145 related articles for article (PubMed ID: 34503844)
1. Preferences of patients regarding community pharmacy services: A discrete choice experiment.
van de Pol JM; Heringa M; Koster ES; Bouvy ML
Health Policy; 2021 Nov; 125(11):1415-1420. PubMed ID: 34503844
[TBL] [Abstract][Full Text] [Related]
2. How does the general public balance convenience and cognitive pharmaceutical services in community pharmacy practice.
van de Pol JM; van Dijk L; Koster ES; de Jong J; Bouvy ML
Res Social Adm Pharm; 2021 Mar; 17(3):606-612. PubMed ID: 32534955
[TBL] [Abstract][Full Text] [Related]
3. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
Naik-Panvelkar P; Armour C; Rose JM; Saini B
Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
[TBL] [Abstract][Full Text] [Related]
5. Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment.
Raghunandan R; Howard K; Marra CA; Tordoff J; Smith A
Appl Health Econ Health Policy; 2021 Mar; 19(2):253-266. PubMed ID: 33073328
[TBL] [Abstract][Full Text] [Related]
6. Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment.
Porteous T; Ryan M; Bond C; Watson M; Watson V
PLoS One; 2016; 11(3):e0152257. PubMed ID: 27031588
[TBL] [Abstract][Full Text] [Related]
7. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
[TBL] [Abstract][Full Text] [Related]
8. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment.
Patterson JA; Holdford DA; Harpe SE
Res Social Adm Pharm; 2019 Jun; 15(6):641-649. PubMed ID: 30143466
[TBL] [Abstract][Full Text] [Related]
10. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
[TBL] [Abstract][Full Text] [Related]
11. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
Yong FR; Hor SY; Bajorek BV
BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
[TBL] [Abstract][Full Text] [Related]
12. The effect of pharmacy setting and pharmacist communication style on patient perceptions and selection of pharmacists.
Perrault EK; Newlon JL
J Am Pharm Assoc (2003); 2018; 58(4):404-411. PubMed ID: 29752206
[TBL] [Abstract][Full Text] [Related]
13. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
Patwardhan PD; Amin ME; Chewning BA
Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' preferences for the provision of services to improve medication adherence among patients with diabetes in Indonesia: Results of a discrete choice experiment.
Presley B; Groot W; Pavlova M
Health Soc Care Community; 2022 Jan; 30(1):e161-e174. PubMed ID: 34009714
[TBL] [Abstract][Full Text] [Related]
15. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
[TBL] [Abstract][Full Text] [Related]
16. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T
Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
Munger MA; Walsh M; Godin J; Feehan M
Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
[TBL] [Abstract][Full Text] [Related]
18. A qualitative exploration of patient preferences for Medicare Part D consultation services offered in a community pharmacy setting.
Murry LT; Witry MJ; Urmie JM
J Am Pharm Assoc (2003); 2023; 63(1):97-107.e3. PubMed ID: 36151025
[TBL] [Abstract][Full Text] [Related]
19. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
20. The Inverse Care Law might not apply to preventative health services in community pharmacy.
Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
